Search - tctmd.com

Displaying 1 - 20 of 32

Sort: Relevancy | Date

News Daily News

IVUS, OCT Each Bring Something to the Table for PCI in Complex Lesions: Meta-analysis

Caitlin E. Cox

January 20, 2026

News Conference News EuroPCR 2024

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

Yael L. Maxwell

May 17, 2024

News Daily News

Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial

Michael O'Riordan

December 27, 2023

News Daily News

P2Y12 Inhibitors Top Aspirin Following Post-PCI DAPT: Network Meta-analysis

Todd Neale

November 21, 2022

News Daily News

Coronary Calcium-Guided Statin Strategy Cost-effective in African-Americans

Michael O'Riordan

May 15, 2020

News Conference News CRT 2020

Meta-analysis Upholds Complete PCI in STEMI, as Thoughts Turn to Timing, Costs

Michael O'Riordan

February 24, 2020

News Daily News

Two Studies Support Safety and Cost-Effectiveness of Same-Day Discharge After Elective PCI

L.A. McKeown

October 04, 2018

News Conference News TCT 2018

TALENT: Indian-Made Supraflex DES Stands Up Well Against Xience in All-Comers

Todd Neale

September 22, 2018

News Daily News

Hybrid Coronary Revascularization at 5 Years: Similar Outcomes to CABG

Yael L. Maxwell

April 23, 2018

News Daily News

Ad Hoc PCI Safe and Feasible in Patients Undergoing TAVR

Leah Lawrence

August 10, 2017

News Daily News

Absorb Comparable to Xience in Economic Analysis, but BVS Safety Concerns Could Alter Balance

Michael O'Riordan

April 18, 2017

News Conference News VIVA 2016

Longer Term, IN.PACT SFA Trial and Global Registry Continue to Support DCB Therapy as an Option

L.A. McKeown

October 12, 2016

News Conference News VIVA 2016

Bioresorbable Scaffold Shows Sustained Promise in Superficial Femoral and Iliac Artery Lesions

L.A. McKeown

September 22, 2016

News Daily News

ILLUMENATE First-in-Human Study: Novel Drug-Coated Balloon Yields Strong 2-Year Outcomes in SFA Lesions

May 30, 2014

News Daily News

Los SLF de 1ª Generación son Menos Rentables que SMD + Rapamicina Oral a los 5 Años

January 06, 2014

Presentation

Comparison of Cost-Effectiveness of Oral Rapamycin Plus BMS vs. First-Generation DES

Presenter: Alfredo E. Rodriguez

December 30, 2013

Presentation TCT 2013

SYNTAX COST-EFFECTIVENESS: Final Five-Year Results from a Prospective, Randomized Trial of Paclitaxel-Eluting Stents vs. CABG in Patients with Triple Vessel and Left Main Corona...

Presenter: David Cohen

October 28, 2013

News Daily News

Oral Sirolimus Appears to Augment Efficacy of BMS

Caitlin E. Cox

August 23, 2013

News Daily News

Zilver PTX 2-Year Results Published: Superior Safety, Efficacy vs. Angioplasty Sustained

April 12, 2013

Presentation TCT 2013

Cost-effectiveness of paclitaxel-coated balloon angioplasty for treatment of coronary restenosis in bare-metal stents

Presenter: Klaus Bonaventura, Alexander Leber, Christian Sohns, Mattias Roser, Leif-Hendrik Boldt, Wilhelm Haverkamp, Marc Dorenkamp

January 31, 2013

Advertisement

IVUS, OCT Each Bring Something to the Table for PCI in Complex Lesions: Meta-analysis

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial

P2Y12 Inhibitors Top Aspirin Following Post-PCI DAPT: Network Meta-analysis

Coronary Calcium-Guided Statin Strategy Cost-effective in African-Americans

Meta-analysis Upholds Complete PCI in STEMI, as Thoughts Turn to Timing, Costs

Two Studies Support Safety and Cost-Effectiveness of Same-Day Discharge After Elective PCI

TALENT: Indian-Made Supraflex DES Stands Up Well Against Xience in All-Comers

Hybrid Coronary Revascularization at 5 Years: Similar Outcomes to CABG

Ad Hoc PCI Safe and Feasible in Patients Undergoing TAVR

Absorb Comparable to Xience in Economic Analysis, but BVS Safety Concerns Could Alter Balance

Longer Term, IN.PACT SFA Trial and Global Registry Continue to Support DCB Therapy as an Option

Bioresorbable Scaffold Shows Sustained Promise in Superficial Femoral and Iliac Artery Lesions

ILLUMENATE First-in-Human Study: Novel Drug-Coated Balloon Yields Strong 2-Year Outcomes in SFA Lesions

Los SLF de 1ª Generación son Menos Rentables que SMD + Rapamicina Oral a los 5 Años

Comparison of Cost-Effectiveness of Oral Rapamycin Plus BMS vs. First-Generation DES

SYNTAX COST-EFFECTIVENESS: Final Five-Year Results from a Prospective, Randomized Trial of Paclitaxel-Eluting Stents vs. CABG in Patients with Triple Vessel and Left Main Corona...

Oral Sirolimus Appears to Augment Efficacy of BMS

Zilver PTX 2-Year Results Published: Superior Safety, Efficacy vs. Angioplasty Sustained

Cost-effectiveness of paclitaxel-coated balloon angioplasty for treatment of coronary restenosis in bare-metal stents

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content